ABVX
Abivax S.A.
105.00$
-1.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +200.0% | +202.4% | -92.1% | +80.0% | -88.9% | +3,050.0% | -41.3% | +12,286.5% | +0.8% | +133.5% | -100.0% | |
| – | -89.5% | +4,144.9% | -0.9% | +6.0% | +83.3% | +19.8% | +34.7% | +11.5% | -98.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | +135.9% | -109.5% | |
| – | – | +1.3% | -29.8% | +46.5% | +82.5% | +19.0% | +38.4% | +1.1% | +113.6% | +42.0% | +21.3% | |
| – | +662.8% | -74.4% | +6.3% | +13.6% | +13.8% | +14.5% | -0.4% | +34.3% | +275.2% | +35.1% | +91.3% | |
| – | +903.6% | -79.3% | -109.3% | – | +36.3% | -17.3% | -197.4% | – | +805.2% | +35.8% | +42.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +158.5% | -75.0% | -26.2% | +1,412.9% | +238.2% | +30.0% | +72.6% | +95.1% | +99.2% | -10.1% | +129.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.